Cantargia: New Biomarker Results in Pancreatic Cancer
Research Note
2023-03-15
14:28
Redeye believes the new biomarker results with nadunolimab to be presented at the AACR Annual Meeting 2023 validate the scientific understanding of nadunolimab.
RR
Richard Ramanius
Disclosures and disclaimers